18 Apr 2019

MHRA issue a reminder for healthcare professionals administering yellow fever vaccine

This alert highlights two reports of fatal adverse reactions to yellow fever vaccine and the importance of a detailed risk assessment before vaccination MHRA issue a reminder for healthcare professionals administering yellow fever vaccine

The Medicines and Healthcare products Regulatory Agency (MHRA) has published an alert following two fatal adverse reactions to yellow fever vaccine. This publication reinforces the importance of a detailed individual risk assessment before administering yellow fever vaccine especially for those who may be immunocompromised or aged 60 years and older. 

NaTHNaC have been working closely with the MHRA following these two reports of fatal adverse reactions. Measures to minimise risks are being reviewed by an Expert Working Group convened by the Commission on Human Medicines and any updates will be highlighted in due course.

Resources

Benin: updated recommendations for polio vaccination

Circulating vaccine derived poliovirus type 2 (cVDPV2) has been confirmed Read more

Myanmar: New outbreak of circulating vaccine derived poliovirus (cVDPV)

Circulating vaccine derived poliovirus type 1 (cVDPV1) has been detected in Kayin Province, Myanmar Read more

Heatwave alert for mainland Europe

Hot weather advice for travellers to mainland European countries Read more

E.coli advice for travellers to Egypt

Public Health England has issued advice to people travelling to Egypt Read more

DRC: Ebola outbreak declared a Public Health Emergency of International Concern

The meeting of the Emergency Committee convened by the WHO Director General under International Health Regulations took place on Wednesday 17 July 2019 Read more
Back to Top

VIEW FULL INDEX